Annual EBITDA
$14.99B$473.00M+3.26%
Summary
- Current Value
- As of today, CVS annual EBITDA is $14.99B, up +3.26% on
- Historical Performance
- CVS annual EBITDA is down -28.05% over the past 3 years, down -18.36% over the past 5 years
- All-Time High Comparison
- CVS annual EBITDA is currently -28.05% below its historical high of $20.83B set on
- 3-Year Low Comparison
- CVS annual EBITDA is +3.26% above its 3-year low of $14.52B reached on
- Sector Comparison
- CVS annual EBITDA is higher than 99.23% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.99B | +3.3% | -28.1% | -18.4% | +96.4% | |
| Quarterly EBITDA | $3.26B | -3.0% | -32.8% | -13.6% | +52.0% | |
| TTM EBITDA | $17.07B | +17.5% | -17.8% | -8.4% | +123.5% | |
| Price | $77.75 | +17.1% | -12.2% | +10.4% | +135.2% | |
| PE Ratio | 56.20 | +209.5% | +105.9% | +336.0% | +323.2% | |
| Annual Revenue | $402.11B | +7.9% | +24.6% | +49.7% | +317.1% | |
| Annual EPS | $1.39 | -62.0% | -57.3% | -74.5% | -44.1% | |
| Annual EBIT | $10.39B | +4.7% | -37.5% | -25.4% | +68.5% | |
| Annual Net Income | $1.73B | -62.3% | -60.1% | -76.0% | -49.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $20.83B | N/A | -28.1% |
| 5Y | $20.83B | -28.1% | |
| All | $20.83B | -28.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $14.52B | +3.3% | |
| 5Y | $14.52B | +3.3% | |
| All | $256.32M | +5748.5% |
EBITDA History
FAQ
What is the current annual EBITDA of CVS?
As of today, CVS annual EBITDA is $14.99B
What is 1-year change in CVS annual EBITDA?
CVS annual EBITDA is up +3.26% year-over-year
What is 3-year change in CVS annual EBITDA?
CVS annual EBITDA is down -28.05% over the past 3 years
How far is CVS annual EBITDA from its all-time high?
CVS annual EBITDA is currently -28.05% below its historical high of $20.83B set on December 31, 2022
How does CVS annual EBITDA rank versus sector peers?
CVS annual EBITDA is higher than 99.23% of companies in Healthcare sector
When is CVS next annual earnings release?
As of today, the next annual earnings release for CVS has not been scheduled
Quarterly EBITDA
$3.26B$834.00M-20.38%
Summary
- Current Value
- As of today, CVS quarterly EBITDA is $3.26B, down -20.38% on
- Historical Performance
- CVS quarterly EBITDA is down -2.98% year-over-year, down -32.80% over the past 3 years
- All-Time High Comparison
- CVS quarterly EBITDA is currently -44.28% below its historical high of $5.85B set on
- 3-Year Low Comparison
- CVS quarterly EBITDA is +2.36% above its 3-year low of $3.18B reached on
- Sector Comparison
- CVS quarterly EBITDA is higher than 99.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $3.26B | -20.4% | -3.0% | -32.8% | -13.6% | |
| Annual EBITDA | $14.99B | – | +3.3% | -28.1% | -18.4% | |
| TTM EBITDA | $17.07B | -0.6% | +17.5% | -17.8% | -8.4% | |
| Price | $77.75 | +1.6% | +17.1% | -12.2% | +10.4% | |
| PE Ratio | 56.20 | -71.9% | +209.5% | +105.9% | +336.0% | |
| Quarterly Revenue | $105.68B | +2.7% | +8.4% | +26.0% | +52.0% | |
| Quarterly EPS | $2.30 | +173.6% | +76.8% | +30.2% | +211.9% | |
| Quarterly EBIT | $2.11B | -28.6% | -4.5% | -44.5% | -19.8% | |
| Quarterly Net Income | $2.92B | +173.3% | +80.1% | +25.3% | +197.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.23B | -37.7% | |
| 3Y | $5.23B | -37.7% | |
| 5Y | $5.85B | -44.3% | |
| All | $5.85B | -44.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.26B | at low | |
| 3Y | $3.18B | +2.4% | |
| 5Y | $3.18B | +2.4% | |
| All | -$3.90B | +183.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CVS?
As of today, CVS quarterly EBITDA is $3.26B
What is CVS quarterly EBITDA most recent change?
CVS quarterly EBITDA was down -20.38% on December 31, 2025
What is 1-year change in CVS quarterly EBITDA?
CVS quarterly EBITDA is down -2.98% year-over-year
How far is CVS quarterly EBITDA from its all-time high?
CVS quarterly EBITDA is currently -44.28% below its historical high of $5.85B set on June 30, 2022
How does CVS quarterly EBITDA rank versus sector peers?
CVS quarterly EBITDA is higher than 99.17% of companies in Healthcare sector
When is CVS next earnings release?
The next earnings release for CVS is on
TTM EBITDA
$17.07B$100.00M-0.58%
Summary
- Current Value
- As of today, CVS TTM EBITDA is $17.07B, down -0.58% on
- Historical Performance
- CVS TTM EBITDA is up +17.54% year-over-year, down -17.79% over the past 3 years
- All-Time High Comparison
- CVS TTM EBITDA is currently -17.79% below its historical high of $20.76B set on
- 3-Year Low Comparison
- CVS TTM EBITDA is +17.54% above its 3-year low of $14.52B reached on
- Sector Comparison
- CVS TTM EBITDA is higher than 99.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $17.07B | -0.6% | +17.5% | -17.8% | -8.4% | |
| Annual EBITDA | $14.99B | – | +3.3% | -28.1% | -18.4% | |
| Quarterly EBITDA | $3.26B | -20.4% | -3.0% | -32.8% | -13.6% | |
| Price | $77.75 | +1.6% | +17.1% | -12.2% | +10.4% | |
| PE Ratio | 56.20 | -71.9% | +209.5% | +105.9% | +336.0% | |
| TTM Revenue | $402.11B | +2.1% | +7.9% | +24.6% | +49.7% | |
| TTM EPS | $1.38 | +261.6% | -62.2% | -57.4% | -74.7% | |
| TTM EBIT | $12.46B | -0.8% | +25.6% | -24.6% | -12.2% | |
| TTM Net Income | $1.73B | +303.7% | -62.3% | -60.1% | -76.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.17B | -0.6% | |
| 3Y | $20.76B | N/A | -17.8% |
| 5Y | $20.76B | -17.8% | |
| All | $20.76B | -17.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.52B | N/A | +17.5% |
| 3Y | $14.52B | +17.5% | |
| 5Y | $14.52B | +17.5% | |
| All | -$3.55B | +580.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CVS?
As of today, CVS TTM EBITDA is $17.07B
What is CVS TTM EBITDA most recent change?
CVS TTM EBITDA was down -0.58% on December 31, 2025
What is 1-year change in CVS TTM EBITDA?
CVS TTM EBITDA is up +17.54% year-over-year
How far is CVS TTM EBITDA from its all-time high?
CVS TTM EBITDA is currently -17.79% below its historical high of $20.76B set on December 31, 2022
How does CVS TTM EBITDA rank versus sector peers?
CVS TTM EBITDA is higher than 99.36% of companies in Healthcare sector
When is CVS next earnings release?
The next earnings release for CVS is on
EBITDA Formula
Data Sources & References
- CVS Official Website www.cvshealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm
- CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
- CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs